Validation of a robust strategy for proton spot scanning for oesophageal cancer in the presence of anatomical changes.

SFUD strategies with one or two posterior proton beams and three target coverage strategies are compared with IMRT and tested for robustness towards anatomical changes by recalculation on surveillance CTs during treatment. We find posterior beam SFUD combining PTV coverage with robust optimization increases robustness towards anatomical changes compared to IMRT.

[1]  Daniel Gomez,et al.  Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study. , 2011, International journal of radiation oncology, biology, physics.

[2]  Anders Forsgren,et al.  Minimax optimization for handling range and setup uncertainties in proton therapy. , 2011, Medical physics.

[3]  T. B. Nyeng,et al.  Dosimetric evaluation of anatomical changes during treatment to identify criteria for adaptive radiotherapy in oesophageal cancer patients , 2015, Acta oncologica.

[4]  S. Apisarnthanarax,et al.  Proton therapy posterior beam approach with pencil beam scanning for esophageal cancer , 2016, Strahlentherapie und Onkologie.

[5]  Li Liao,et al.  Motion-robust intensity-modulated proton therapy for distal esophageal cancer. , 2016, Medical physics.

[6]  J. Langendijk,et al.  Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer? , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  G. Starkschall,et al.  Impact of gastric filling on radiation dose delivered to gastroesophageal junction tumors. , 2010, International journal of radiation oncology, biology, physics.

[8]  Shinji Sato,et al.  Moving target irradiation with fast rescanning and gating in particle therapy. , 2010, Medical physics.

[9]  Christoph Bert,et al.  Target motion tracking with a scanned particle beam. , 2007, Medical physics.

[10]  K. Ohtomo,et al.  Patient setup error and day-to-day esophageal motion error analyzed by cone-beam computed tomography in radiation therapy , 2010, Acta oncologica.

[11]  J. Slater,et al.  Analysis of Intensity-Modulated Radiation Therapy (IMRT), Proton and 3D Conformal Radiotherapy (3D-CRT) for Reducing Perioperative Cardiopulmonary Complications in Esophageal Cancer Patients , 2014, Cancers.

[12]  Lei Dong,et al.  A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties. , 2012, International journal of radiation oncology, biology, physics.

[13]  Christian Graeff,et al.  Motion mitigation in scanned ion beam therapy through 4D-optimization. , 2014, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[14]  C. Hurt,et al.  An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning , 2016, International journal of radiation oncology, biology, physics.

[15]  Joe Y. Chang,et al.  Clinical controversies: proton therapy for thoracic tumors. , 2013, Seminars in radiation oncology.

[16]  T. Alderliesten,et al.  Interfractional variability of respiration-induced esophageal tumor motion quantified using fiducial markers and four-dimensional cone-beam computed tomography. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  T. Hashimoto,et al.  Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose–volume histogram analysis , 2015, Journal of radiation research.

[18]  Tanja Alderliesten,et al.  Quantification of respiration-induced esophageal tumor motion using fiducial markers and four-dimensional computed tomography. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  R. Mohan,et al.  Proton beam therapy and concurrent chemotherapy for esophageal cancer. , 2012, International journal of radiation oncology, biology, physics.

[20]  J. Ajani,et al.  Predictors of postoperative complications after trimodality therapy for esophageal cancer. , 2013, International journal of radiation oncology, biology, physics.

[21]  Hisao Ito,et al.  Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. , 2009, International journal of radiation oncology, biology, physics.

[22]  E. Steyerberg,et al.  Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. , 2015, The Lancet. Oncology.

[23]  I. Olver,et al.  Oesophageal cancer: Which treatment is the easiest to swallow? A review of combined modality treatments for resectable carcinomas. , 2017, Critical reviews in oncology/hematology.

[24]  Lei Dong,et al.  Physics controversies in proton therapy. , 2013, Seminars in radiation oncology.

[25]  Tatsuya Nakamura,et al.  Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I–III esophageal cancer , 2016, Cancer medicine.

[26]  Radhe Mohan,et al.  Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer. , 2008, International journal of radiation oncology, biology, physics.